GoodRx Holdings, Inc.

NasdaqGS:GDRX Stock Report

Market Cap: US$1.6b

GoodRx Holdings Past Earnings Performance

Past criteria checks 0/6

GoodRx Holdings has been growing earnings at an average annual rate of 16.4%, while the Healthcare Services industry saw earnings growing at 14% annually. Revenues have been growing at an average rate of 11.6% per year.

Key information

16.4%

Earnings growth rate

14.0%

EPS growth rate

Healthcare Services Industry Growth1.7%
Revenue growth rate11.6%
Return on equity-2.3%
Net Margin-2.1%
Last Earnings Update30 Sep 2024

Recent past performance updates

Recent updates

GoodRx Holdings, Inc.'s (NASDAQ:GDRX) Shares May Have Run Too Fast Too Soon

Oct 29
GoodRx Holdings, Inc.'s (NASDAQ:GDRX) Shares May Have Run Too Fast Too Soon

GoodRx: The Tide Is Turning The Wrong Way (Rating Downgrade)

Oct 26

GoodRx Holdings: Failing To Gain Much Traction

Oct 08

GoodRx Holdings' (NASDAQ:GDRX) Returns On Capital Not Reflecting Well On The Business

Sep 22
GoodRx Holdings' (NASDAQ:GDRX) Returns On Capital Not Reflecting Well On The Business

GoodRx Q2 Earnings Preview

Jul 31

GoodRx Holdings (NASDAQ:GDRX) Could Easily Take On More Debt

Jul 12
GoodRx Holdings (NASDAQ:GDRX) Could Easily Take On More Debt

GoodRx Holdings, Inc.'s (NASDAQ:GDRX) 30% Price Boost Is Out Of Tune With Revenues

Jun 09
GoodRx Holdings, Inc.'s (NASDAQ:GDRX) 30% Price Boost Is Out Of Tune With Revenues

Returns On Capital At GoodRx Holdings (NASDAQ:GDRX) Paint A Concerning Picture

Jun 06
Returns On Capital At GoodRx Holdings (NASDAQ:GDRX) Paint A Concerning Picture

GoodRx: Encouraging Profit Stabilization (Rating Upgrade)

May 28

GoodRx Holdings: Large TAM Continues To Support Growth

Mar 20

GoodRx Holdings, Inc. (NASDAQ:GDRX) Stock Rockets 26% As Investors Are Less Pessimistic Than Expected

Mar 07
GoodRx Holdings, Inc. (NASDAQ:GDRX) Stock Rockets 26% As Investors Are Less Pessimistic Than Expected

Is GoodRx Holdings, Inc. (NASDAQ:GDRX) Trading At A 24% Discount?

Mar 01
Is GoodRx Holdings, Inc. (NASDAQ:GDRX) Trading At A 24% Discount?

GoodRx Holdings (NASDAQ:GDRX) Has A Rock Solid Balance Sheet

Feb 12
GoodRx Holdings (NASDAQ:GDRX) Has A Rock Solid Balance Sheet

GoodRx: Cost Saving Is A Strong Value Proposition To Consumers

Jan 23

GoodRx Holdings (NASDAQ:GDRX) May Have Issues Allocating Its Capital

Jan 22
GoodRx Holdings (NASDAQ:GDRX) May Have Issues Allocating Its Capital

GoodRx Stock Spikes After Receiving A Strong Dose Of Performance

Jan 11

What Is GoodRx Holdings, Inc.'s (NASDAQ:GDRX) Share Price Doing?

Dec 02
What Is GoodRx Holdings, Inc.'s (NASDAQ:GDRX) Share Price Doing?

GoodRx Holdings (NASDAQ:GDRX) May Have Issues Allocating Its Capital

Sep 12
GoodRx Holdings (NASDAQ:GDRX) May Have Issues Allocating Its Capital

An Intrinsic Calculation For GoodRx Holdings, Inc. (NASDAQ:GDRX) Suggests It's 41% Undervalued

Jul 14
An Intrinsic Calculation For GoodRx Holdings, Inc. (NASDAQ:GDRX) Suggests It's 41% Undervalued

GoodRx Holdings' (NASDAQ:GDRX) Returns On Capital Not Reflecting Well On The Business

May 27
GoodRx Holdings' (NASDAQ:GDRX) Returns On Capital Not Reflecting Well On The Business

Some Confidence Is Lacking In GoodRx Holdings, Inc. (NASDAQ:GDRX) As Shares Slide 27%

May 05
Some Confidence Is Lacking In GoodRx Holdings, Inc. (NASDAQ:GDRX) As Shares Slide 27%

Investors Give GoodRx Holdings, Inc. (NASDAQ:GDRX) Shares A 27% Hiding

May 05
Investors Give GoodRx Holdings, Inc. (NASDAQ:GDRX) Shares A 27% Hiding

Is There An Opportunity With GoodRx Holdings, Inc.'s (NASDAQ:GDRX) 45% Undervaluation?

Mar 23
Is There An Opportunity With GoodRx Holdings, Inc.'s (NASDAQ:GDRX) 45% Undervaluation?

GoodRx Holdings (NASDAQ:GDRX) May Have Issues Allocating Its Capital

Feb 07
GoodRx Holdings (NASDAQ:GDRX) May Have Issues Allocating Its Capital

Revenue & Expenses Breakdown

How GoodRx Holdings makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

NasdaqGS:GDRX Revenue, expenses and earnings (USD Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Sep 24790-16475115
30 Jun 24775-59487124
31 Mar 24764-7460125
31 Dec 23750-9451126
30 Sep 2373815418141
30 Jun 2374512426137
31 Mar 23747-48448141
31 Dec 22767-33465143
30 Sep 22796-71519141
30 Jun 22803-47515141
31 Mar 22788-15513135
31 Dec 21745-25525126
30 Sep 21686-282792114
30 Jun 21631-31483395
31 Mar 21578-31076478
31 Dec 20551-29471562
30 Sep 205101335748
30 Jun 204727523440
31 Mar 204355021734
31 Dec 193884219229
31 Dec 182501411344

Quality Earnings: GDRX is currently unprofitable.

Growing Profit Margin: GDRX is currently unprofitable.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: GDRX is unprofitable, but has reduced losses over the past 5 years at a rate of 16.4% per year.

Accelerating Growth: Unable to compare GDRX's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: GDRX is unprofitable, making it difficult to compare its past year earnings growth to the Healthcare Services industry (13.9%).


Return on Equity

High ROE: GDRX has a negative Return on Equity (-2.33%), as it is currently unprofitable.


Return on Assets


Return on Capital Employed


Discover strong past performing companies